SCHEMBL4438003

SCHEMBL4438003

CCCCOC(=O)N(c1ccncc1[N+](=O)[O-])C1CCCNC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PCSK9 Q8NBP7 10/20 0.36
RPLP1 P05386 6/20 0.34
RPLP0 P05388 6/20 0.34
RPS17 P08708 6/20 0.34
RPSA P08865 6/20 0.34
RPS2 P15880 6/20 0.34
RPL35A P18077 6/20 0.34
RPL7 P18124 6/20 0.34
RPL17 P18621 6/20 0.34
RPS4Y1 P22090 6/20 0.34
RPS3 P23396 6/20 0.34
RPS12 P25398 6/20 0.34
RPL13 P26373 6/20 0.34
RPL10 P27635 6/20 0.34
RPL12 P30050 6/20 0.34
RPL9; RPL9P7; RPL9P8; RPL9P9 P32969 6/20 0.34
RPL22 P35268 6/20 0.34
RPL4 P36578 6/20 0.34
RPS19 P39019 6/20 0.34
RPL3 P39023 6/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4445165 0.88 RPLP1 (0.35) PCSK9RPLP1RPLP0RPS17RPSA
SCHEMBL8223035 0.85 PCSK9 (0.37) PCSK9RPLP1RPLP0RPS17RPSA
SCHEMBL4443619 0.83 RPLP1 (0.35) PCSK9RPLP1RPLP0RPS17RPSA
SCHEMBL3412292 0.83 RPLP1 (0.35) PCSK9RPLP1RPLP0RPS17RPSA
SCHEMBL3412297 0.83 RPLP1 (0.35) PCSK9RPLP1RPLP0RPS17RPSA
SCHEMBL3408546 0.83 MEN1 (0.39) PCSK9RPLP1RPLP0RPS17RPSA
SCHEMBL4436116 0.78 SLC6A4 (0.34) KCNH2MEN1KMT2A
SCHEMBL4444504 0.76 RPLP1 (0.35) PCSK9RPLP1RPLP0RPS17RPSA
SCHEMBL6121183 0.73 MAPT (0.40) KCNH2ALDH1A1TDP1L3MBTL1LMNA
SCHEMBL3412104 0.69 JAK2 (0.33) ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed